The utility of the Contrast Enhanced endoscopic ultrasound in guiding fine needle aspiration for PANcreatic masses

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN10282426

Enrollment

Registered

2013-08-08

Start date

2013-03-28

Completion date

Unknown

Last updated

2019-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic mass Cancer Malignant neoplasm of pancreas

Interventions

This is a non-randomized study. In each prospectively examined patient with pancreatic masses on CT scan, Endoscopic Ultrasound - Fine Needle Aspiration (EUS- FNA) was performed using a 22 G needle, f

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Any gender and age above 18 years old with pancreatic mass. Pancreatic mass detected by ultrasonography or computerised tomography (CT) scan

Exclusion criteria

Exclusion criteria: 1. History of chemotherapy 2. Coagulation disorders 3. Patient?s refuse

Design outcomes

Primary

Measure	Time frame
Diagnostic accuracy of FNA guided by conventional endoscopic ultrasound (EUS)	—

Secondary

Measure	Time frame
Combination of the time to peak obtained by quantitative assessment of the contrast image with CEH-EUS-FNA pathologic results	—

Countries

Romania

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026